Genscript Biotech Corporation (01548.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.9x

Market Cap

HKD 69.09B

MomentumView details →

1D Return

−13.33%

YTD Return

+153.30%

RSI (14)

57.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.9x

Market Cap

HKD 69.09B

RSI (14)

57.0

MomentumView details →

1D Return

−13.33%

YTD Return

+153.30%

ProfitabilityView details →

Gross Margin

53.71%

Net Margin

148.03%

EBITDA Margin

26.05%

ROE (TTM)

63.71%

ROA (TTM)

51.71%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

+16.05%

EPS YoY

—

FCF YoY

+130.44%

Revenue CAGR 3Y

+15.32%

EPS CAGR 3Y

—

EBITDA YoY

+178.79%

EarningsView details →

EPS (Actual)

−HKD 0.46

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

5.28%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

1.48x

Quick Ratio

1.42x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.67B

Net Income (TTM)

2.48B

Op. CF (TTM)

—

Next earningsMar 24, 2027 →

Latest newsMore news →

On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.16d ago

Similar companies

荣昌生物688331.SH argenx SEARGX Encell Co. Ltd.456070.KQ Moderna, Inc.MRNA Regeneron Pharmaceuticals, Inc.REGN Amicogen, Inc.092040.KQ Find similar companies →

Latest newsMore news →

On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.16d ago